RFK Jr. to Link Tylenol to Autism

RFK Jr. to Link Tylenol to Autism

The News

Shares of Kenvue fell more than 10% on Friday after a report that Health and Human Services Secretary Robert F. Kennedy Jr. will likely link autism to the use of the company’s pain medication Tylenol in pregnant women.

HHS will release the report that could draw that link this month, the Wall Street Journal reported on Friday.

That report will also suggest a medicine derived from folate – a water-soluble vitamin – can be used to treat symptoms of the developmental disorder in some people, according to the Journal.

Reactions

In a statement, an HHS spokesperson said “We are using gold-standard science to get to the bottom of America’s unprecedented rise in autism rates.”

“Until we release the final report, any claims about its contents are nothing more than speculation,” they added.

In a statement, Kenvue said it has “continuously evaluated the science and [continues] to believe there is no causal link” between the use of acetaminophen, the generic name for Tylenol, during pregnancy and autism.

The company added that the Food and Drug Administration and leading medical organizations “agree on the safety” of the drug, its use during pregnancy and the information provided on the Tylenol label.

In a note on Friday, BNP Paribas analyst Navann Ty said the firm believes the “hurdle to proving causation [between the drug and autism] is high, particularly given that the litigation previously concluded in Kenvue’s favor.”

More

Tylenol could be the latest widely used and accepted treatment that Kennedy has undermined at the helm of HHS, which oversees federal health agencies that regulate drugs and other therapies. Kennedy has also taken steps to change vaccine policy in the U.S., and has amplified false claims about safe and effective shots that use mRNA technology.

Kennedy has made the disorder a key focus of HHS, pledging in April that the agency will “know what has caused the autism epidemic” by September and eliminate exposures. He also said that month that the agency has launched a “massive testing and research effort” involving hundreds of scientists worldwide that will determine the cause.

The FDA website says the agency has not found “clear evidence” that appropriate use of acetaminophen during pregnancy causes “adverse pregnancy, birth, neurobehavioral, or developmental outcomes.” But the FDA said it advises pregnant women to speak with their health-care providers before using over-the-counter drugs.

The American College of Obstetricians and Gynecologists maintains that acetaminophen is safe during pregnancy when taken as directed and after consulting a health-care provider.

Some previous studies have suggested the drug poses risks to fetal development, and some parents have brought lawsuits claiming that they gave birth to children with autism after using it.

But a federal judge in Manhattan ruled in 2023 that some of those lawsuits lacked scientific evidence and later ended the litigation in 2024. Some research has also found no association between acetaminophen use and autism.

Charleston White Arrested Again on Florida Battery Charge

Border Patrol Rescues MS NOW Crew in Desert

Supreme Court Restores Missouri's Old House Map

Alaska Drops Felony Voter Charges Against Samoans

Trespasser Breaches Harris' Malibu Estate; No Arrest

Hegseth Pressed Downed Airmen Into 60 Minutes

Houthis Seize Mokha, Choking Saudi Oil Exports

Altman Rules Out OpenAI IPO This Year

Jury Acquits Lil Durk in Murder-for-Hire Case

Judge: Trump Broke Law Halving FEMA Staff

Maher Calls Democrats' Gaza Genocide Claim a Lie

Blizzard Revives StarCraft, Sends Diablo to Netflix

Trump's Queens Childhood Home Sells for $1.93M

Scientists Find New Virus in Tick Invading US

Britain Bans Settlement Imports; US States Threaten Payback

Prison Fire Kills 7 as Kurds Protest Killing

Kosovo Rallies for Ex-President Before Hague Verdict

Cruz Booed at GameDay Over College Sports Bill

Blast Hits Bulgarian Arms Plant Supplying Ukraine

DOJ Loses Nearly Every Protester Assault Trial